Table 1. Characteristics of study participants.
| Variables | Overall (n=492) | African American (n=248) | White American (n=244) | P valuea |
|---|---|---|---|---|
| Demographic factors | ||||
| Education | 0.126 | |||
| ≤ High school/GED | 210 (43.1) | 109 (51.9) | 101(48.1) | |
| Some college | 130 (26.7) | 73 (56.2) | 57 (43.8) | |
| ≥ College degree | 147 (30.2) | 65 (44.2) | 82 (55.8) | |
| Gender | 0.377 | |||
| Female | 302 (61.4) | 157 (52.0) | 145 (48.0) | |
| Male | 190 (38.6) | 91 (47.9) | 99 (52.1) | |
| Income | <0.0001† | |||
| <$30,000 | 174 (37.3) | 115 (66.1) | 59 (33.9) | |
| $30,000–$50,000 | 142 (30.4) | 62 (43.7) | 80 (56.3) | |
| >$50,000 | 151 (32.3) | 64 (42.4) | 87 (57.6) | |
| Health insurance status | 0.0022† | |||
| Uninsured | 56 (11.4) | 39 (69.6) | 17 (30.4) | |
| Insured | 436 (88.6) | 209 (47.9) | 227 (52.1) | |
| Employment status | 0.034* | |||
| Employed | 213 (43.9) | 96 (45.1) | 117 (54.9) | |
| Unemployed | 272 (56.1) | 149 (54.8) | 123 (45.2) | |
| Clinical factors | ||||
| Age at diagnosis (years) | 0.0280* | |||
| 26–49 | 95 (19.3) | 56 (58.9) | 39 (41.1) | |
| 50–64 | 207 (42.1) | 111 (53.6) | 96 (46.4) | |
| 65–74 | 129 (26.2) | 58 (45.0) | 71 (55.0) | |
| 75+ | 61 (12.4) | 23 (37.7) | 38 (62.3) | |
| Cancer site | 0.127 | |||
| Colorectal | 101 (21.2) | 42 (41.6) | 59 (58.4) | |
| Breast | 237 (49.9) | 127 (53.6) | 110 (46.4) | |
| Prostate | 137 (28.8) | 70 (51.1) | 67 (48.9) | |
| Currently in treatment | 0.136 | |||
| Yes | 98 (20.0) | 56 (57.1) | 42 (42.9) | |
| No | 392 (80.0) | 191 (48.7) | 201 (51.3) | |
| Cancer stage at diagnosis | 0.49 | |||
| Stage I and II | 171 (34.7) | 86 (50.3) | 85 (49.7) | |
| Stage III and IV | 45 (9.2) | 19 (42.2) | 26 (57.8) | |
| Unknown | 276 (56.1) | 143 (51.8) | 133 (48.2) | |
| Time since diagnosis (months) | 0.798 | |||
| ≤12 months | 89 (18.1) | 41 (46.1) | 48 (53.9) | |
| 13 to 18 months | 144 (29.3) | 76 (52.8) | 68 (47.2) | |
| 19 to 24 months | 171 (34.7) | 86 (50.3) | 85 (49.7) | |
| >24 months | 88 (17.9) | 45 (51.1) | 43 (48.9) | |
| Medical comorbidities | 0.0015† | |||
| Yes | 289 (58.7) | 163 (56.4) | 126 (43.6) | |
| No | 203 (41.3) | 85 (41.9) | 118 (58.1) | |
| Quality of life | ||||
| Physical health QOL | 46.02±11.13 | 44.53±10.89 | 47.54±11.20 | 0.0026† |
| Mental health QOL | 52.62±9.44 | 51.58±9.97 | 53.67±8.76 | 0.0135* |
a, P value was obtained from Chi-Square test and Mann-Whitney U test. *, P<0.05; †, P<0.01. Sample sizes vary due to missing data.